ADVERTISEMENT
Lupin, Alkem Face 'Higher Risk' Of U.S. FDA Inspections, Cipla Least At Risk: Jefferies
Q4FY21 saw 10 product recalls from Alkem, Alembic, Dr. Reddy’s, Lupin, Sun Pharma and Zydus Cadila: Jefferies
01 Apr 2021, 12:30 PM IST
Pharmaceutical product recalls in the three months ended March jumped to the highest in four quarters, according to Jefferies, raising the risk of inspections by the U.S. Food and Drug Administration. 10 product recalls from Alkem Laboratories Ltd., Alembic Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Ltd., Sun Pharmaceutical Industries Ltd., and Zydus Cadila, have been reported in the January-March period, the research firm sai...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Members-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
Stories
20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Members-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT